P\S\L Restructures and Hires Group President

In New York, pharma specialist P\S\L Group has appointed Paul Barnes to the new position of Group President in charge of its recently restructured research division.

The division, P\S\L Research Group, comprises P\S\L Research International, P\S\L Research Europe and P\S\L Research Canada.

Barnes joins with more than 20 years' global pharma market research experience, the past 12 of which he spent with TNS, latterly as President of the firm's TNS Healthcare unit in the US (www.mrweb.com/drno/news4479.htm ). Prior to this, he worked clientside in sales and marketing roles with Glaxo and Lederle.

'With the creation of business groups, PSL is providing a framework for continued growth of the network of research, medical information and education businesses,' said Michele Fearon, CEO of P\S\L Group. 'This structure will create an executive management team for each major business field and encourage the emergence of several new business units. We are delighted to welcome Paul to the organisation.'earch database of more than 400,000 physicians, P\S\L conducts testing and tracking research for pharmaceutical and healthcare organisations. Its web site is at www.pslresearch.com.

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.